Send the following on WhatsApp
Continue to Chat百濟神州(BeiGene)百悅澤®(澤布替尼)獲歐盟委員會批准,用於治療邊緣區淋巴瘤成人患者 https://geneonline.news/%e7%99%be%e6%bf%9f%e7%a5%9e%e5%b7%9e%ef%bc%88beigene%ef%bc%89%e7%99%be%e6%82%85%e6%be%a4%ef%bc%88%e6%be%a4%e5%b8%83%e6%9b%bf%e5%b0%bc%ef%bc%89%e7%8d%b2%e6%ad%90%e7%9b%9f%e5%a7%94%e5%93%a1/?variant=zh-cn